Odi Bruckman retweeted
Novo Nordisk reports surging sales trib.al/4QgXC2e
Odi Bruckman retweeted
Moderna and @LonzaPB announce worldwide strategic collaboration to manufacture Moderna's #vaccine (mRNA-1273) against novel coronavirus. Read more: buff.ly/2Yn8LtG #mRNA
Odi Bruckman retweeted
#Breaking: Pivotal data evaluating spinal muscular atrophy (SMA) medicine shows study met its primary endpoint in infants with Type 1 #SMA. gene.com/media/press-release…
Odi Bruckman retweeted
#COVID19 $GILD Japan's Prime Minister, Shinzō Abe, says coronavirus drug candidate remdesivir may soon be granted special approval.
reuters.com/article/brief-ja…
Odi Bruckman retweeted
The WHO and the leaders of France and Germany launch an $8 billion drive to accelerate development of a coronavirus vaccine trib.al/WdMMDQQ
Odi Bruckman retweeted
A mass testing in the Italian town of Vo’ Euganeo, in the northeast of Italy, found more than 40% of those infected had no symptoms trib.al/p4IL43w
Odi Bruckman retweeted
Key U.S. lawmaker pushes for a ban on mergers until coronavirus pandemic ends reuters.com/article/us-healt…
Odi Bruckman retweeted
Coronavirus stockpiling drives best Nestle sales growth in years reuters.com/article/us-nestl…
Odi Bruckman retweeted
Columbia's coronavirus plasma therapy study will be funded by $2.5 million from Amazon. cnb.cx/2Kxv2gg
$AXGT Announces Full Prepayment of Outstanding Loan from Hercules Capital globenewswire.com/news-relea…
Odi Bruckman retweeted
Lysol maker urges people not to inject disinfectants after Trump remarks streetinsider.com/General+Ne…
Odi Bruckman retweeted
Maker of Lysol after Trump comments: 'Under no circumstance' should people inject, ingest disinfectants bit.ly/2KuqGXl
$AZN $MRK Lynparza demonstrated overall survival benefit in Phase III PROfound trial for BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer astrazeneca.com/media-centre…
$PSTI Secures €50M Non-Dilutive Financing from the European Investment Bank to Support its COVID-19 Project and Phase III Studies globenewswire.com/news-relea…















